|author||Jong Seung Kim|
|journal||Sci. Rep. 29018, 6, 2016.|
We report here a tumor-targeting masked phototherapeutic agent 1 (PT-1). This system contains SN-38—a prodrug of the topoisomerase I inhibitor irinotecan. Topoisomerase I is a vital enzyme that controls DNA topology during replication, transcription, and recombination. An elevated level of topoisomerase I is found in many carcinomas, making it an attractive target for the development of effective anticancer drugs. In addition, PT-1 contains both a photo-triggered moiety (nitrovanillin) and a cancer targeting unit (biotin). Upon light activation in cancer cells, PT-1 interferes with DNA re-ligation, diminishes the expression of topoisomerase I, and enhances the expression of inter alia mitochondrial apoptotic genes, death receptors, and caspase enzymes, inducing DNA damage and eventually leading to apoptosis. In vitro andin vivo studies showed significant inhibition of cancer growth and the hybrid system PT-1 thus shows promise as a programmed photo-therapeutic (“phototheranostic”).
« Prev Adsorption of Carbon Dioxide on Unsaturated Metal Sites in M2...Adsorption of Carbon Dioxide on Unsaturated Metal Sites in M2... 2016.07.24by 〈
Probing Distinct Fullerene Formation Processes from Carbon Pr... Next »Probing Distinct Fullerene Formation Processes from Carbon Pr... 2016.07.22by 〉
Designed by sketchbooks.co.kr / sketchbook5 board skin